Literature DB >> 520752

Comparative study of in vivo development of resistance to various classes of antitumor agents in P388 leukemia.

M Inaba, R Fujikura, Y Sakurai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520752

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


× No keyword cloud information.
  4 in total

1.  Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.

Authors:  T Tsuruo; Y Sudo; N Asami; M Inaba; M Morimoto
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.

Authors:  E Kobayashi; M Okabe; M Kono; H Arai; M Kasai; K Gomi; J H Lee; M Inaba; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.

Authors:  C Etievant; J M Barret; A Kruczynski; D Perrin; B T Hill
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

4.  Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.

Authors:  M Kobayashi; T Natsume; S Tamaoki; J Watanabe; H Asano; T Mikami; K Miyasaka; K Miyazaki; M Gondo; K Sakakibara; S Tsukagoshi
Journal:  Jpn J Cancer Res       Date:  1997-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.